Advertisment

Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:747

Official publication of the Indian Society of Nephrology
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Efficacy and safety of canagliflozin in kidney transplant patients

Shah Mita, Virani Zaheer, Rajput Prashant, Shah Bharat

Year : 2019| Volume: 29| Issue : 4 | Page no: 278-281

   This article has been cited by
 
1 New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
Marc Evans, Angharad R. Morgan, Martin B. Whyte, Wasim Hanif, Stephen C. Bain, Philip A. Kalra, Sarah Davies, Umesh Dashora, Zaheer Yousef, Dipesh C. Patel, W. David Strain
Drugs. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Incretin based therapies and SGLT-2 inhibitors in kidney transplant recipients with diabetes: A systematic review and meta-analysis
Dora Oikonomaki, Evangelia Dounousi, Anila Duni, Stefanos Roumeliotis, Vassilios Liakopoulos
Diabetes Research and Clinical Practice. 2021; 172: 108604
[Pubmed]  [Google Scholar] [DOI]
3 Long-term efficacy and safety of anti-hyperglycaemic agents in new-onset diabetes after transplant: Results from outpatient-based 1-year follow-up and a brief review of treatment options
Debmalya Sanyal, Mansij Biswas, Nayan Chaudhari
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021; 15(1): 13
[Pubmed]  [Google Scholar] [DOI]
4 Use of Sodium-Glucose Cotransporter-2 Inhibitors in Renal Transplant Patients With Diabetes: A Brief Review of the Current Literature
Shirley Shuster, Zeyana Al-Hadhrami, Sarah Moore, Sara Awad, M. Khaled Shamseddin
Canadian Journal of Diabetes. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Efficacy and safety of Sodium-Glucose-Transporter-2 inhibitors in kidney transplant patients
Trond G. Jenssen
Current Opinion in Nephrology & Hypertension. 2021; 30(6): 577
[Pubmed]  [Google Scholar] [DOI]
6 Safety and Efficacy of Sodium-glucose Cotransporter 2 Inhibitors in Kidney Transplant Recipients With Pretransplant Type 2 Diabetes Mellitus: A Retrospective, Single-center, Inverse Probability of Treatment Weighting Analysis of 85 Transplant Patients
Yu Hisadome, Takanori Mei, Hiroshi Noguchi, Toshiaki Ohkuma, Yu Sato, Keizo Kaku, Yasuhiro Okabe, Masafumi Nakamura
Transplantation Direct. 2021; 7(11): e772
[Pubmed]  [Google Scholar] [DOI]
7 Sodium-glucose cotransporter 2 inhibitors for diabetes mellitus control after kidney transplantation: Review of the current evidence
Mehmet Kanbay, Atalay Demiray, Baris Afsar, Kagan E. Karakus, Alberto Ortiz, Mads Hornum, Adrian Covic, Pantelis Sarafidis, Peter Rossing
Nephrology. 2021; 26(12): 1007
[Pubmed]  [Google Scholar] [DOI]
8 Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics
Manfred Hecking, Adnan Sharif, Kathrin Eller, Trond Jenssen
Transplant International. 2021; 34(1): 27
[Pubmed]  [Google Scholar] [DOI]
9 Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation
Lale A. Ertuglu, Esteban Porrini, Mads Hornum, Atalay Demiray, Baris Afsar, Alberto Ortiz, Adrian Covic, Peter Rossing, Mehmet Kanbay
Transplant International. 2021; 34(8): 1341
[Pubmed]  [Google Scholar] [DOI]
10 Review of Newer Antidiabetic Agents for Diabetes Management in Kidney Transplant Recipients
Sonya Anderson, Laura Cotiguala, Sarah Tischer, Jeong Mi Park, Katie McMurry
Annals of Pharmacotherapy. 2021; 55(4): 496
[Pubmed]  [Google Scholar] [DOI]
11 Early Post–Renal Transplant Hyperglycemia
Anira Iqbal, Keren Zhou, Sangeeta R Kashyap, M Cecilia Lansang
The Journal of Clinical Endocrinology & Metabolism. 2021;
[Pubmed]  [Google Scholar] [DOI]
12 Global Epidemiology, Health Outcomes, and Treatment Options for Patients With Type 2 Diabetes and Kidney Failure
Jessica Phillips, Jenny H. C. Chen, Esther Ooi, Janelle Prunster, Wai H. Lim
Frontiers in Clinical Diabetes and Healthcare. 2021; 2
[Pubmed]  [Google Scholar] [DOI]
13 Chronic Kidney Allograft Disease: New Concepts and Opportunities
Sergi Codina, Anna Manonelles, Maria Tormo, Anna Sola, Josep M. Cruzado
Frontiers in Medicine. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
14 New-Onset Diabetes after Kidney Transplantation
Claudio Ponticelli, Evaldo Favi, Mariano Ferraresso
Medicina. 2021; 57(3): 250
[Pubmed]  [Google Scholar] [DOI]
15 Current Pharmacological Intervention and Medical Management for Diabetic Kidney Transplant Recipients
Theerawut Klangjareonchai, Natsuki Eguchi, Ekamol Tantisattamo, Antoney J. Ferrey, Uttam Reddy, Donald C. Dafoe, Hirohito Ichii
Pharmaceutics. 2021; 13(3): 413
[Pubmed]  [Google Scholar] [DOI]
16 Sodium-Glucose Cotransporter 2 Inhibitors and Kidney Transplantation: What Are We Waiting For?
Niralee Patel, Judy Hindi, Samira S. Farouk
Kidney360. 2021; 2(7): 1174
[Pubmed]  [Google Scholar] [DOI]
17 Recent advances in new-onset diabetes mellitus after kidney transplantation
Tess Montada-Atin, G V Ramesh Prasad
World Journal of Diabetes. 2021; 12(5): 541
[Pubmed]  [Google Scholar] [DOI]
18 Managing cardiovascular disease risk in South Asian kidney transplant recipients
G V Ramesh Prasad, Vaishnavi Bhamidi
World Journal of Transplantation. 2021; 11(6): 147
[Pubmed]  [Google Scholar] [DOI]
19 Efficacy and Safety of SGLT-2 Inhibitors for Treatment of Diabetes Mellitus among Kidney Transplant Patients: A Systematic Review and Meta-Analysis
Api Chewcharat, Narut Prasitlumkum, Charat Thongprayoon, Tarun Bathini, Juan Medaura, Saraschandra Vallabhajosyula, Wisit Cheungpasitporn
Medical Sciences. 2020; 8(4): 47
[Pubmed]  [Google Scholar] [DOI]
20 Two Japanese patients with stage G3b chronic kidney disease and impaired glucose metabolism after renal transplantation successfully treated with empagliflozin
Ryoichi Miyazaki, Kyoko Miyagi, Misaki Yoshida
Renal Replacement Therapy. 2020; 6(1)
[Pubmed]  [Google Scholar] [DOI]
21 Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the Italian Diabetes Society (SID)
Caterina Conte, Umberto Maggiore, Gianni Cappelli, Giuseppe Ietto, Quirino Lai, Paola Salis, Piero Marchetti, Lorenzo Piemonti, Antonio Secchi, Enzo Capocasale, Rossana Caldara
Nutrition, Metabolism and Cardiovascular Diseases. 2020; 30(9): 1427
[Pubmed]  [Google Scholar] [DOI]
22 Effectiveness and safety of sodium–glucose co-transporter-2 inhibitors in Thai adults with type 2 diabetes mellitus: a real-world study
Chutintorn Sriphrapradang, Yotsapon Thewjitcharoen, Supawan Buranapin, Kittisak Sawanyawisuth, Nalin Yenseung, Wisawa Ubonchareon, Laddawan Limpijankit, Thep Himathongkam
Current Medical Research and Opinion. 2020; 36(10): 1601
[Pubmed]  [Google Scholar] [DOI]

 

© Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07